Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/48662f4a-8744-4fe1-93ac-99e51a282bc8/

CNSL

Cambridge Nutritional Sciences plc
Chart
£1.85
Latest Week 2026-06-05
HealthcareMedical Instruments & SuppliesSMALL
Snapshot 2026-06-07 · 0.0w · Fresh
0.6
OS Score
95.0%
Value
16.0%
Quality
8.0%
Momentum
#54.00000000
TV Rank
4/9
F-Score
0.390
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
VC2 9.00000000
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
95.0%ile
P/E
281.1×
P/S
52.8×
P/B
39.8×
E/P
0.0036
FCF Yield
-0.001
EBITDA/EV
0.005
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
5.00000000
/100 — 1=cheapest
VC2 (Trending Value)
9.00000000
/100
VC3 (Buyback)
8.00000000
/100
P/E of 281.1x is premium-priced — the market is paying up for expected growth. Negative FCF yield (-0.1%) — the business is currently cash-consumptive. VC2 score of 9.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
16.0%ile
ROE
0.142
ROA
0.123
Net Margin
0.188
Op Margin
-0.047
GPA
0.429
Current
4.25
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.148
Accruals
0.128
lower=better
5yr Consist
No
Accruals ratio of 0.128 is elevated — earnings quality may be lower than headline numbers suggest.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
8.0%ile
6M Return
-7.5%
12M Return
-42.2%
12-1 Mom
-32.8%
Risk-Adj
-0.83
Vol 252d
39.3%
Vol 60d
91.6%
↑ Expanding
Max DD 12M
-51.9%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -33% signals a downtrend — price is moving against you. Near-term vol (92%) is expanding vs long-term (39%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.6
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 75 peers
Sector Value %ile
100.0%
Sector Quality %ile
26.3%
P/E z-score
-1.45
P/B z-score
-0.37
Sector Avg OS
33.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
BVC BATM Advanced Communications Ltd. 79.0% 64.0% 62.0% 63.0%
AVCT Avacta Group Plc 79.0% 64.0% 62.0% 63.0%
SPI Spire Healthcare Group plc 77.0% 73.0% 75.0% 29.0%
HIK Hikma Pharmaceuticals PLC 75.0% 82.0% 71.0% 11.0%
CRTX CRISM Therapeutics Corporation 75.0% 62.0% 60.0% 61.0%
CVSG CVS Group plc 74.0% 61.0% 60.0% 61.0%
CIZ Cizzle Biotechnology Holdings Plc 73.0% 61.0% 59.0% 60.0%
CHLL Chill Brands Group PLC 73.0% 61.0% 59.0% 60.0%
Factor Interactions
Cheap for a Reason?
Looks cheap (95th value) but weak quality (16th). Classic value trap risk.
Falling Knife
Weak momentum (8th) despite looking cheap (95th value). Wait for momentum to stabilise.
Volatility Expanding
60-day vol (92%) significantly exceeds 252-day (39%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
4.2% avg (7 factors)
Quality
C
53.8% avg (7 factors)
Momentum
F
8.1% avg (4 factors)
Risk
C
51.1% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.600—0—
Value %ile0.950—1—
Quality %ile0.160—1—
Momentum %ile0.080—1—
F-Score4.000—1—
Confidence0.637—0—
Volatility0.393—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
281.10
Earnings Yield (E/P)
0.0036
Price / Sales
52.85
Price / Book
39.82
FCF Yield
-0.1%
EBITDA / EV
0.5%
Sales Yield (1/P·S)
0.0191
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
14.2%
Return on Assets
12.3%
Net Margin
18.8%
Operating Margin
-4.7%
Gross Profit / Assets
Novy-Marx GPA
42.9%
Current Ratio
4.25
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.128
MomentumPrice trend strength over different horizons
6M Return
-7.5%
12M Return
-42.2%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-32.8%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.83
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-14.8%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
5
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
9
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
8
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
54
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity